{"id":"https://openalex.org/W7221328149","doi":"https://doi.org/10.7759/cureus.117750","title":"Attitudes Among Physician Associates Regarding Naloxone Prescribing for the Treatment of Opioid Overdose","display_name":"Attitudes Among Physician Associates Regarding Naloxone Prescribing for the Treatment of Opioid Overdose","publication_year":2026,"publication_date":"2026-10-10","ids":{"openalex":"https://openalex.org/W7221328149","doi":"https://doi.org/10.7759/cureus.117750","pmid":"https://pubmed.ncbi.nlm.nih.gov/43011136","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13748493"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117750","doi":"https://doi.org/10.7759/cureus.117750","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117750","pdf_url":"https://www.cureus.com/articles/514713-attitudes-among-physician-associates-regarding-naloxone-prescribing-for-the-treatment-of-opioid-overdose.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/514713-attitudes-among-physician-associates-regarding-naloxone-prescribing-for-the-treatment-of-opioid-overdose.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5158241906","display_name":"Amanda Novak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Amanda Novak","raw_affiliation_strings":["Pain/Addiction, Wayspring, Nashville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pain/Addiction, Wayspring, Nashville, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5099135135","display_name":"Kirsten Brondstater","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200033832","display_name":"Shenandoah University","ror":"https://ror.org/05w0p9h92","country_code":"US","type":"education","lineage":["https://openalex.org/I200033832"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirsten N Brondstater","raw_affiliation_strings":["Family and Community Medicine, Shenandoah University, Winchester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Family and Community Medicine, Shenandoah University, Winchester, USA","institution_ids":["https://openalex.org/I200033832"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5158241906"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10","first_page":"e117750","last_page":"e117750"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naloxone-prescribing","display_name":"naloxone prescribing","score":0.8119999766349792},{"id":"https://openalex.org/keywords/opioid-overdose","display_name":"opioid overdose","score":0.8029999732971191},{"id":"https://openalex.org/keywords/physician-assistants","display_name":"physician assistants","score":0.9610000252723694},{"id":"https://openalex.org/keywords/prescribing-attitudes","display_name":"prescribing attitudes","score":0.7369999885559082},{"id":"https://openalex.org/keywords/barriers-to-prescribing","display_name":"barriers to prescribing","score":0.875},{"id":"https://openalex.org/keywords/overdose-prevention","display_name":"overdose prevention","score":0.8539999723434448},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.6480000019073486},{"id":"https://openalex.org/keywords/stigma","display_name":"stigma","score":0.5690000057220459},{"id":"https://openalex.org/keywords/physician-training","display_name":"physician training","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9775999784469604},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.8023999929428101},{"id":"https://openalex.org/C2779148768","wikidata":"https://www.wikidata.org/wiki/Q17154378","display_name":"Opioid overdose","level":5,"score":0.7944999933242798},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5210999846458435},{"id":"https://openalex.org/C2776315796","wikidata":"https://www.wikidata.org/wiki/Q3505252","display_name":"Drug overdose","level":3,"score":0.4853000044822693},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4726000130176544},{"id":"https://openalex.org/C2910999556","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid abuse","level":4,"score":0.42399999499320984},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.37279999256134033},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.34599998593330383},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.33059999346733093},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.31299999356269836},{"id":"https://openalex.org/C2909816603","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid-Related Disorders","level":5,"score":0.27559998631477356},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.27549999952316284},{"id":"https://openalex.org/C3017944768","wikidata":"https://www.wikidata.org/wiki/Q1450463","display_name":"Poison control","level":2,"score":0.2721000015735626},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.27090001106262207},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2639000117778778},{"id":"https://openalex.org/C2910878864","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonists","level":5,"score":0.2581000030040741},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.25690001249313354},{"id":"https://openalex.org/C2781072394","wikidata":"https://www.wikidata.org/wiki/Q407541","display_name":"Fentanyl","level":2,"score":0.25380000472068787},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2506999969482422}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.7759/cureus.117750","doi":"https://doi.org/10.7759/cureus.117750","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117750","pdf_url":"https://www.cureus.com/articles/514713-attitudes-among-physician-associates-regarding-naloxone-prescribing-for-the-treatment-of-opioid-overdose.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmid:43011136","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43011136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.117750","doi":"https://doi.org/10.7759/cureus.117750","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117750","pdf_url":"https://www.cureus.com/articles/514713-attitudes-among-physician-associates-regarding-naloxone-prescribing-for-the-treatment-of-opioid-overdose.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221328149.pdf","grobid_xml":"https://content.openalex.org/works/W7221328149.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1836101929","https://openalex.org/W3135229644","https://openalex.org/W3159907295","https://openalex.org/W3185145203","https://openalex.org/W4308369850","https://openalex.org/W4386621396","https://openalex.org/W4389113546","https://openalex.org/W4402042377","https://openalex.org/W4403381541","https://openalex.org/W4405507114"],"related_works":["https://openalex.org/W2403243872","https://openalex.org/W2994589854","https://openalex.org/W2990821241","https://openalex.org/W2258331748","https://openalex.org/W4387823351","https://openalex.org/W4409668412","https://openalex.org/W4327900280","https://openalex.org/W4415072422","https://openalex.org/W2079938984","https://openalex.org/W4224998220"],"abstract_inverted_index":{"Objective":[0],"This":[1,35,47],"study":[2,41],"aims":[3],"to":[4,20,52,103,144,165],"explore":[5],"and":[6,11,44,64,73,88,100,106,121,135,160],"better":[7],"understand":[8],"current":[9],"attitudes":[10,118],"barriers":[12,99,143],"among":[13],"physician":[14],"associates":[15],"(PAs)":[16],"toward":[17,119],"naloxone":[18,32,83,120,169],"prescribing":[19,98,109],"inform":[21],"efforts":[22],"that":[23,153],"support":[24,89],"wider":[25],"adoption":[26],"of":[27,82,111,149],"overdose":[28,122],"prevention":[29],"strategies":[30],"through":[31],"prescribing.":[33,146,170],"Methods":[34],"is":[36,163],"a":[37,85],"cross-sectional,":[38],"descriptive":[39],"survey":[40,49,151],"with":[42],"quantitative":[43],"qualitative":[45],"components.":[46],"33-question":[48],"was":[50],"distributed":[51],"PAs":[53,69,114,162],"who":[54],"have":[55],"graduated":[56],"from":[57],"an":[58],"accredited":[59],"PA":[60],"program":[61],"via":[62],"email":[63],"social":[65],"media.":[66],"Results":[67,95],"Ninety":[68],"across":[70],"34":[71],"states":[72],"27":[74],"specialties":[75],"completed":[76],"the":[77,93,108],"survey.":[78],"Respondents":[79],"affirm":[80],"use":[81],"as":[84,141],"life-saving":[86],"intervention":[87],"its":[90],"normalization":[91],"in":[92,137,156,167],"community.":[94],"also":[96],"identified":[97,140],"potential":[101,142],"opportunities":[102],"decrease":[104],"stigma":[105],"increase":[107],"rates":[110],"naloxone.":[112],"Conclusions":[113],"demonstrated":[115],"broadly":[116],"favorable":[117],"prevention;":[123],"however,":[124],"time":[125],"constraints,":[126],"concerns":[127],"regarding":[128,132],"patient":[129],"perceptions,":[130],"uncertainty":[131],"state-specific":[133],"laws,":[134],"gaps":[136],"confidence":[138],"were":[139],"routine":[145],"The":[147],"results":[148],"this":[150],"suggest":[152],"further":[154],"work":[155],"developing":[157],"real-world":[158],"insights":[159],"educating":[161],"likely":[164],"result":[166],"increased":[168]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-10-11T00:00:00"}